ProstaGene's Unattributed Round

ProstaGene raised a round of funding on March 10, 2015.

ProstaGene is a biotechnology start up company that integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for can…

Articles about ProstaGene's Unattributed Round: